CompaniesByCap
AVTX
Avalo Therapeutics Inc. (AVTX)
NASDAQ · Healthcare

Avalo Therapeutics Inc. Price to FCF Ratio 2015–2026

Price to free cash flow (P/FCF) ratio for Avalo Therapeutics Inc. (AVTX): market cap divided by trailing twelve-month free cash flow. As of September 30, 2018 it is 37116.17.
From: 09/30/2017To: 09/30/2025
Stock Price
TTM Free Cash Flow
Price to FCF

Avalo Therapeutics Inc. Price to FCF Ratio — FAQ

Avalo Therapeutics Inc. (AVTX) price to fcf ratio over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AVTX's price to fcf ratio history?

The chart and table above show Avalo Therapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.